TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

Coloplast A/S - Full-Year Financial Results 2024/25

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Coloplast A/S
Coloplast A/S - Full-Year Financial Results 2024/25

Coloplast reported 7% organic growth and a 28% EBIT margin for fiscal year 2024/25, with strong performance in Chronic Care businesses and continued market share gains across regions except China. The company expects around 7% organic revenue growth in 2025/26.

Insights
MSFT   positive

Top holding in both ETFs, suggesting consistent performance and growth characteristics


CLPBY   positive

Delivered 7% organic growth, increased EBIT margin from 27% to 28%, strong performance in most business areas, and positive guidance for next fiscal year